{"id":"W2980414489","doi":"","title":"Tofacitinib in the Treatment of Rheumatoid Arthritis and Chronic Plaque Psoriasis.","year":2017,"lang":"en","type":"article","venue":"PubMed","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lynde Centre for Dermatology; Mediprobe Research (Canada)","funders":"","keywords":"Tofacitinib; Psoriasis; Medicine; Rheumatoid arthritis; Janus kinase inhibitor; Dermatology; Adverse effect; Janus kinase; Clinical trial; Plaque psoriasis; Psoriatic arthritis; Upper respiratory tract infection; Placebo; Arthritis; Internal medicine; Pharmacology; Pathology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000519811,0.0003879637,0.0004385313,0.0007040335,0.0002301018,0.0004224239,0.0002082233,0.0005809253,0.007048503],"category_scores_gemma":[0.0004329818,0.00006961192,0.000341364,0.0006187833,0.0001819537,0.0003195422,0.0002702709,0.001070622,0.002509998],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003860201,"about_ca_system_score_gemma":0.0005323635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009138106,"about_ca_topic_score_gemma":0.002932291,"domain_scores_codex":[0.9998705,0.00002734954,0.00001536222,0.00001509275,0.00004948169,0.00002217657],"domain_scores_gemma":[0.9998412,0.00003254346,0.00004351575,0.000004343587,0.00003461889,0.00004378333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001134806,0.0002035506,0.0006964052,0.00215647,0.00008587384,0.0007765735,0.00005167969,0.0001702184,0.004571045,0.002327751,0.06066342,0.9271622],"study_design_scores_gemma":[0.002860686,0.002446736,0.006520336,0.001340783,0.0002659427,0.009092524,0.00008056743,0.0004057195,0.003621959,0.003176694,0.9701602,0.00002776233],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.007792183,0.9485584,0.0005578539,0.006274974,0.001855828,0.00007270518,0.0004232789,0.0001007003,0.0343641],"genre_scores_gemma":[0.1286133,0.8129974,0.0028026,0.00818181,0.003657621,0.0001209292,0.002106655,0.00003425921,0.04148546],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.007048503,"threshold_uncertainty_score":0.02357966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02794259072132384,"score_gpt":0.2704593553754652,"score_spread":0.2425167646541414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}